Genocea Biosciences, Inc.

Home » Genocea Biosciences, Inc.

Secondary

Genocea Biosciences, Inc.

Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies.

Symbol

GNCA

Last Closing Price
$1.08

Shares
50,000,000

Effective Date
January 17, 2018

Underwriters
Cantor Fitzgerald

To view the prospectus for Genocea Biosciences, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253